Mission & History

The mission of ACGT is to support the extraordinary potential offered by cell and gene-based therapies to accelerate effective and safe treatment of all types of cancer.

Our Commitment

ACGT is committed to building alliances between philanthropic individuals and organizations, and medical and academic institutions, to promote gene therapy research to combat cancer.

To this end, ACGT will identify, fund and monitor innovative research that meets a rigorous set of scientific standards, and has the potential, in the foreseeable future, to treat cancers of all types.

Through this endeavor, ACGT will educate the public about the potential for cancer gene therapy and facilitate greater collaborations among the scientific community to foster the best possible research and ultimately the best treatment.

History

2016
2015
2014
2013
2012
2011
2010
  • $1.5 million awarded to two researchers for Clinical Translation Research
  • RFA for Young Investigators posted; 49 abstracts from 31 institutions submitted and there are 4 finalists
  • Swim Across America 4th Annual Greenwich-Stamford Swim with over 200 swimmers raised over $300,000 to benefit ACGT
  • “Celebrating Progress” Gala Fundraiser in April raises more than $500,000
2009
2008
2007
  • Began offering Clinical Translation of Gene Therapy Investigator Grants; 45 abstracts from 33 institutions submitted; 26 invited to submit complete applications; there are 11 finalists
  • $3.0 million awarded to three researchers for Clinical Translation Research
  • Swim Across America First Annual Greenwich Swim raises $200,000 to benefit ACGT
  • RFA for Young Investigators posted July 2007; 65 abstracts from 46 institutions respond and there are 7 finalists. $1.0 million awarded to two Young Investigators
2006
2005
  • RFA posted for Leukemia & Lymphoma Cancer Gene Therapy Research; 24 applicants from 22 institutions respond and there are 12 finalists
  • $3.0 million awarded to three researchers for Leukemia & Lymphoma Cancer Gene Therapy Research
  • RFA for Young Investigators posted; 51 applicants from 39 institutions respond and there are 18 finalists
  • $1.0 million awarded to four Young Investigators
2004
  • RFA posted for Leukemia & Lymphoma Cancer Gene Therapy Research; 21 applicants from 19 institutions respond and there are 10 finalists
  • $2.0 million awarded to two researchers for Leukemia & Lymphoma Cancer Gene Therapy Research
  • RFA for Young Investigators posted; 49 applicants from 34 institutions respond and there are 22 finalists
  • $1.7 million awarded to four Young Investigators
2003
  • RFA for Young Investigators posted; 44 applicants from 36 institutions respond and there are 21 finalists
  • ACGT joins American Society of Gene & Cell Therapy
  • $2.5 million awarded to five Young Investigators
2002
2001

Alliance for Cancer Gene Therapy, Inc. [ACGT] is a 501 [c] [3] non-profit public charity founded in 2001 by Barbara and Edward Netter to facilitate funding for high-potential research into cell and gene therapies, in the hopes of realizing an effective alternative to the treatment and management of cancer.